Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs

• Eli Lilly said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company’s pipeline of small molecule drugs, including its closely watched experimental obesity pill. 
• It is the second in a string of four new planned U.S. plants by the drugmaker, which will all begin making medicine within five years.
• The added production capacity for Eli Lilly’s obesity pill, orforglipron, is crucial as the company races to bring it to market and tries to maintain its dominance in the booming market for GLP-1s

Source: https://www.cnbc.com/2025/09/23/eli-lilly-plans-6point5-billion-texas-manufacturing-plant-for-obesity-pill.html